Skip to main content

Goeddel David V's Form 4 filing

RAPT Therapeutics, Inc. (RAPT) · filed May 12, 2022

Accession no.
0000899243-22-017787
Filed
May 12, 2022, 5:28 PM ET
Trade date
May 10, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $13.3M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Goeddel David VCIK 000118246410% Owner
Column Group II, LPCIK 000160042010% Owner
Svennilson PeterCIK 000160607410% Owner
Kutzkey TimCIK 000161418610% Owner
Column Group II GP, LPCIK 000164533310% Owner
Ponoi Capital, LPCIK 000170723010% Owner
Ponoi Management, LLCCIK 000172070210% Owner
Ponoi Capital II, LPCIK 000173260110% Owner
Ponoi II Management, LLCCIK 000174648810% Owner
Column Group LLCCIK 000183348610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 10, 2022Common StockPPurchaseAcquired+1,208,750$10.67+$12,899,175.631,208,750Indirect
May 10, 2022Common StockPPurchaseAcquired+41,250$10.67+$440,199.3841,250Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)